Skip to main content

Lanomax as a Drug in Cataract Treatment: A Case Study

Abstract

The possibility of determining lanosterol, the active ingredient of the drug Lanomax, in the lacrimal fluid by a new electrochemical method of multisensory stripping voltammetry was studied. The measurements were carried out using a planar solid-state electrode. The test-system solution was a 0.05 М KCl solution, which contained the Zn2+, Cd2+, Pb2+, Cо2+ and Hg2+ metal cations at the concentration of 5 · 10–5 M. It was shown that the method is effective for the determination of lanosterol; the dynamics of the change in its concentration in time was considered. It was also shown that the lanosterol concentration in the lacrimal fluid remains constant for 12 h. The possibility of nonsurgical dissolution of cataracts in humans using Lanomax was investigated. In the course of the dynamic observation of this process for 8 months, the stabilization of rapidly progressive cataract was found.

This is a preview of subscription content, access via your institution.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.

REFERENCES

  1. 1

    I. I. Kolesnichenko, V. M. Ganshin, A. N. Doronin, and V. P. Lukovtsev, in Measurement and Information Technologies in Health Protection^ Proc. Int. Sci. Conf. (St. Petersburg, 2011), pp 164–173. [in Russian]

  2. 2

    I. I. Kolesnichenko, V. M. Ganshin, A. L. Klyuev, et al., in Mesurements in the Modern World: Proc. 4th Int. Sci.-Pract. Conf. (St. Petersburg State Ped. Univ., St. Petersburg, 2013), pp. 189–198 [in Russian].

  3. 3

    I. I. Kolesnichenko, E. P. Kantarzhi, L. M. Balashova, in Fundamental Physico-Mathematical Problems and Technocal-Technological System Modeling, Vol. 17 (Moscow, 2016), pp. 103–114 [in Russian].

    Google Scholar 

  4. 4

    I. I. Kolisnichenko, A. L. Klyuev, V. M. Ganshin, et al., Prot. Met. Phys. Chem. Surf. 50 (4), 543 (2014).

    Article  Google Scholar 

  5. 5

    L. M. Balashova, I. I. Kolesnichenko, E. P. Kantarzhi, Klin. Gerontol. 23 (9–10), 6 (2017).

  6. 6

    I. I. Kolesnichenko, E. P. Kantarzhi, and A. N. Doronin, in Mesurements in the Modern World: Proc. 6th Int. Sci.-Pract. Conf. (St. Petersburg State Ped. Univ., St. Petersburg, 2017), pp. 33–37 [in Russian].

  7. 7

    Eye Diseases, Ed. by V. G. Kopaeva (Meditsina, Moscow, 2002) [in Russian].

    Google Scholar 

  8. 8

    L. Zhao, X.-J. Chen, J. Zhu, et al., Nature 523, 607 (2015). doi 10.1038/nature14650

    ADS  Article  Google Scholar 

  9. 9

    P. M. Shanmugam, A. Barigali, J. Kadaskar, et al., Ind. J. Ophthalmol. 63 (12), 888 (2015). doi 10.4103/0301-4738.176040

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to V. A. Namiot.

Additional information

Translated by D. Novikova

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Balashova, L.M., Namiot, V.A., Kolesnichenko, I.I. et al. Lanomax as a Drug in Cataract Treatment: A Case Study. BIOPHYSICS 63, 655–661 (2018). https://doi.org/10.1134/S0006350918040024

Download citation

Keywords:

  • dynamic observation
  • cataract
  • stabilization
  • lanomax
  • multisensory stripping voltammetry in the form of electronic tongue
  • lacrimal fluid